|
ZYG11B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.026150E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.731800E-02 |
| Normal-vs-Stage2 |
4.148500E-02 |
| Normal-vs-Stage3 |
2.010400E-01 |
| Normal-vs-Stage4 |
5.538200E-01 |
| Stage1-vs-Stage2 |
3.693000E-01 |
| Stage1-vs-Stage3 |
7.158800E-01 |
| Stage1-vs-Stage4 |
3.905400E-01 |
| Stage2-vs-Stage3 |
2.723600E-01 |
| Stage2-vs-Stage4 |
1.702420E-01 |
| Stage3-vs-Stage4 |
5.881400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.768000E-01 |
| Normal-vs-AfricanAmerican |
6.930800E-01 |
| Normal-vs-Asian |
6.661700E-02 |
| Caucasian-vs-AfricanAmerican |
1.626810E-01 |
| Caucasian-vs-Asian |
3.756600E-01 |
| AfricanAmerican-vs-Asian |
5.699700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.862400E-01 |
| Normal-vs-Female |
7.798500E-02 |
| Male-vs-Female |
4.338200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.225200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.020210E-01 |
| Normal-vs-Age(61-80Yrs) |
1.119590E-01 |
| Normal-vs-Age(81-100Yrs) |
2.550800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.358000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.966400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.865600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.696400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.100000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.235200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.481800E-01 |
| Classical-VS-Follicular |
4.52920000004742E-06 |
| Classical-VS-Other |
1.311250E-01 |
| Classical-VS-Normal |
6.072400E-01 |
| Tall-VS-Follicular |
3.519200E-03 |
| Tall-VS-Other |
1.215760E-01 |
| Tall-VS-Normal |
7.652400E-01 |
| Follicular-VS-Other |
9.472200E-01 |
| Follicular-VS-Normal |
2.410200E-04 |
| Other-VS-Normal |
1.029810E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.623600E-03 |
| Normal-vs-N1 |
7.655500E-02 |
| N0-vs-N1 |
7.434200E-01 |
|
|
